Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | VIPR2 | P41587 | 19/20 | 0.57 |
| ▸ | MMP1 | P03956 | 1/20 | 0.48 |
| ▸ | MMP2 | P08253 | 1/20 | 0.48 |
| ▸ | MMP9 | P14780 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6465881 | 1.00 | VIPR2 (0.57) | VIPR2MMP1MMP2MMP9 | |
| SCHEMBL6469198 | 0.87 | VIPR2 (0.55) | VIPR2 | |
| SCHEMBL6469195 | 0.87 | VIPR2 (0.55) | VIPR2 | |
| SCHEMBL6469450 | 0.85 | VIPR2 (0.54) | VIPR2MMP1MMP2MMP9 | |
| SCHEMBL6469452 | 0.85 | VIPR2 (0.54) | VIPR2MMP1MMP2MMP9 | |
| SCHEMBL6468238 | 0.84 | MMP1 (0.64) | VIPR2MMP1MMP2MMP9 | |
| SCHEMBL6466122 | 0.82 | VIPR2 (0.69) | VIPR2MMP1MMP2MMP9 | |
| SCHEMBL6468083 | 0.82 | VIPR2 (0.62) | VIPR2MMP2MMP9 | |
| SCHEMBL6469322 | 0.82 | VIPR2 (0.64) | VIPR2MMP1MMP2MMP9 | |
| SCHEMBL7300250 | 0.81 | VIPR2 (0.70) | VIPR2MMP1MMP2MMP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2016094706-A1 | CURABLE NANO-COMPOSITES FOR ADDITIVE MANUFACTURING OF LENSES | SCHMUTZ IP, LLC (US) | 2016-06-16 | — | — | WO | claimed |
| US-20050038019-A1 | Hydroxy substituted amides for the treatment of alzheimer's disease | PHARMACIA & UPJOHN | 2005-02-17 | — | — | US | claimed |
| EP-1443923-A1 | HYDROXY SUBSTITUTED AMIDES FOR THE TREATMENT OF ALZHEIMER'S DISEASE | Elan Pharmaceuticals, Inc. (US) | 2004-08-11 | — | — | EP | claimed |
| WO-2003037325-A1 | HYDROXY SUBSTITUTED AMIDES FOR THE TREATMENT OF ALZHEIMER'S DISEASE | ELAN PHARMACEUTICALS, INC. (US) | 2003-05-08 | — | — | WO | claimed |
| EP-3615641-A1 | LUBRICATING COMPOSITION | Shell Internationale Research Maatschappij B.V. (NL) | 2020-03-04 | — | — | EP | disclosed |
| WO-2018197312-A1 | LUBRICATING COMPOSITION | SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V. (NL) | 2018-11-01 | — | — | WO | disclosed |
| EP-3227414-B1 | USE FOR REDUCING LOW SPEED PRE-IGNITION | SHELL INT RESEARCH (NL) | 2018-09-12 | — | — | EP | disclosed |
| EP-3227414-A1 | METHOD FOR REDUCING LOW SPEED PRE-IGNITION | Shell Internationale Research Maatschappij B.V. (NL) | 2017-10-11 | — | — | EP | disclosed |
| EP-3197986-A1 | LUBRICATING COMPOSITION | Shell Internationale Research Maatschappij B.V. (NL) | 2017-08-02 | — | — | EP | disclosed |
| EP-3158034-A1 | LUBRICATING COMPOSITION | Shell Internationale Research Maatschappij B.V. (NL) | 2017-04-26 | — | — | EP | disclosed |
| WO-2016184842-A1 | LUBRICATING COMPOSITION | SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V. (NL) | 2016-11-24 | — | — | WO | disclosed |
| WO-2016156328-A1 | USE OF A LUBRICATING COMPOSITION COMPRISING A HINDERED AMINE LIGHT STABILIZER FOR IMPROVED PISTON CLEANLINESS IN AN INTERNAL COMBUSTION ENGINE | SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V. (NL) | 2016-10-06 | — | — | WO | disclosed |
| CN-104099169-B | A kind of composite calcium sulfonate grease lubricant and preparation method thereof | 山东北方淄特特种油股份有限公司 | 2016-06-29 | — | — | CN | disclosed |
| WO-2016087379-A1 | METHOD FOR REDUCING LOW SPEED PRE-IGNITION | SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V. (NL) | 2016-06-09 | — | — | WO | disclosed |
| WO-2016046133-A1 | LUBRICATING COMPOSITION | SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V. (NL) | 2016-03-31 | — | — | WO | disclosed |
| WO-2016032782-A1 | METHODS FOR LUBRICATING A DIAMOND-LIKE CARBON COATED SURFACE, ASSOCIATED LUBRICATING OIL COMPOSITIONS AND ASSOCIATED SCREENING METHODS | SHELL OIL COMPANY (US) | 2016-03-03 | — | — | WO | disclosed |
| WO-2015193395-A1 | LUBRICATING COMPOSITION | SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V. (NL) | 2015-12-23 | — | — | WO | disclosed |
| US-20050038019-A1 | Hydroxy substituted amides for the treatment of alzheimer's disease | PHARMACIA & UPJOHN | 2005-02-17 | — | — | US | disclosed |
| EP-1454316-A2 | LUBRICANT FOR MAGNETIC RECORDING MEDIUM AND USE THEREOF | Pennzoil-Quaker State Company (US) | 2004-09-08 | — | — | EP | disclosed |
| WO-2003030151-A2 | LUBRICANT FOR MAGNETIC RECORDING MEDIUM AND USE THEREOF | PENNZOIL-QUAKER STATE COMPANY (US) | 2003-04-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050038019-A1 | Hydroxy substituted amides for the treatment of alzheimer's disease | BACE1, APP, BACE2 | VIPR2 2131/4885MMP1 1095/4885MMP2 357/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.